Arkitekt Ventures invests in entrepreneurs who transform cutting edge science and technology into solutions aimed at improving and advancing human health.

Arkitekt Ventures

Arkitekt Ventures is an early stage venture capital firm, with a mission to improve and advance human health. We partner with exceptional founders building the next generation of Health & Bio companies.
contact@arkitektventures.com

One week left to apply for our Arkitekt Venture Fellowship program!

👉 Our program is a tailored six-month, immersive experience designed to expose the right candidate to different facets of venture capital. The Fellowship position is especially valuable for candidates interested in healthcare venture capital or those with healthcare/life science entrepreneurial ambitions. You will work directly with the Partners of the firm on due diligence, IP landscaping, market research and deal evaluation. The position is fully remote, unpaid and on part-time 7 hrs/week commitment. 

CC: Arkitekt Ventures Pavan Choksi
https://lnkd.in/e6gYbqB7

Grateful to be making Business Insider's The Seed 40 List: Best women early-stage investors of 2024, and be amongst friends, colleagues and legend investors!

Even more grateful for the rockstar founders I've backed, whose crazy hard work enabled me to be on that list Andrea Coravos, Robin Berzin MD, Samuel Whitaker, Carolyn Witte, Felicity Yost, Sahil Choudhry, Kwasi Kyei, Oded Eran, Lauren Makler, Halle Tecco, Brad Olson, Sean Kevlahan, Anshul Rathi, Chris Mirabile and many more!

Thanks Rebecca Torrence, Matt Turner and Termina for the rankings! 

CC Arkitekt Ventures, Pavan Choksi

https://lnkd.in/e5ip2Jdb

Huge congrats to our Managing Director Enke Bashllari, Ph.D. on being named to Business Insider’s The Seed 40: The best women early-stage investors of 2024 list!! 🎉

Well deserved recognition for the best early stage healthcare & bio investor committed to improving and advancing human health!

https://lnkd.in/eyHSf9GA

Arkitekt Ventures

Jimini's novel therapy approach is now live in Florida, California and Colorado!  Try it out at www.jiminihealth.com! 
Luis, Mark & Sahil have developed a novel mental health care model that is both evidence-based AND continuous via text-based therapy.  Because therapy should not be limited to a 1-hr session or the patient's access to a qualified therapist.

This is how we scale & improve mental healthcare across the world.

To those aspiring to drive advances in health and bio, please note the upcoming Jan 3 deadline for the MS/MBA Biotech program at Harvard. This unique dual degree program offers an MBA from @Harvard Business School and an MS from @Harvard Medical School, integrating business acumen with scientific expertise.

We're proud to have our Managing Director Enke Bashllari, Ph.D. serve as an advisor for the program, bringing her wealth of experience to the program's development. If you're passionate about making a significant impact in life sciences or healthcare this program is for you. 

Apply by January 3rd, 2024. 

Learn more below:
https://lnkd.in/ekxx_Pvf

#Harvard #biotechnology #lifesciences #health #hbs

Metric
Company Name	Arkitekt Ventures
Symbol
MSH ID	COM:ARKITEKTVENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	14
Website	arkitektventures.com
LinkedIn	arkitektventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	41
Web Traffic Growth	-0.91
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ARKITEKTVENTURES

Arkitekt Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue